Clinical Trial Update: Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).

View source ↗

Summary

Long-term follow-up analysis of non-Hodgkin's lymphoma patients who received Plerixafor or placebo in the AMD3100-3101 trial to assess outcomes after autologous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Mozobil (plerixafor)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Non-Hodgkin's Lymphoma, Autologous Transplantation | Status: COMPLETED